Kyu Hasegawa

Fujita Health University

Papers

1

Total Citations

25

H-Index

1

About

Dr. Kyu Hasegawa is a leading urologic oncologist whose research focuses on optimizing surgical outcomes for bladder cancer patients, particularly through minimally invasive techniques. His most impactful work investigates the risk factors for postoperative ileus following robot‑assisted radical cystectomy with intracorporeal urinary diversion—a highly complex procedure. In a seminal 2022 study (25 citations), Dr. Hasegawa retrospectively analyzed 78 patients to identify clinical predictors of this common complication, providing actionable insights that help surgeons reduce recovery times and improve patient quality of life. His contributions are central to advancing robotic urologic surgery, balancing oncologic efficacy with enhanced recovery protocols. By systematically evaluating perioperative variables, Dr. Hasegawa has helped establish evidence‑based guidelines that are now informing practice in major cancer centers. His work continues to shape the future of bladder cancer surgery, making him a respected voice in the field of urologic oncology and surgical outcomes research.

Research Focus

Key Achievements

1
H-Index
1
Papers
25
Total Citations
25
Avg Citations/Paper
🏆 Most Cited Paper
Risk factors for postoperative ileus after robot‐assisted radical cystectomy with intracorporeal urinary diversion
25 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Fujita Health University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago